Annakaisa Haapasalo Group (Molecular Neurodegeneration)

01.06.2015 -
Our research focus lies in the genetic background and molecular mechanisms underpinning neurodegenerative diseases, especially frontotemporal dementia (FTD). We utilize a variety of in vitro and in vivo model systems and patient-derived cells, clinical samples and data. We are especially interest...

UEF Neurodegeneration - Myohanen Lab

02.08.2021 -
Our research group is focused on studying the mechanisms and drug targets in neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, aiming to develop a disease-modifying therapy.

Neurobiology of disease

24.10.2017 -
The main goal of our research is to understand the mechanisms that lead to neurodegenerative diseases and to identify novel therapeutic approaches for them. We are interested in the effects of environmental factors (such as air pollution and viral infections) and lifestyle factors on brain healt...

Neuropharmacology and Drug Targets Consortium (NDTC)

01.01.2022 -
NDTCs vision: Diseases of the CNS share common pathological mechanisms and increased understanding of neuroscience and pharmacology of neural system will lead to therapeutic options in diseases with incomplete or unmet medical need.

NDTCs mission: We decipher and unravel common pa...

Sweelin Chew

Postdoctoral Researcher , A.I. Virtanen Institute for Molecular Sciences

Multiple Sclerosis - research group

Our specific aims are:

To elucidate the role of neurodegeneration in multiple sclerosis using modern brain imaging and OCT methods in correlation with clinical variables and biomarkers. We also evaluate the correlation of heart rate variability and autonomic dysfunction with neuro...

Nadine Huber

Early Stage Researcher , A.I. Virtanen Institute for Molecular Sciences